Advances in biotechnological processes最新文献

Biotechnology in Agriculture 农业生物技术

Advances in biotechnological processes Pub Date : 1993-01-01 DOI: 10.1007/978-94-011-1779-1

C. You, Zhang-liang Chen, Yong Ding

引用次数: 31

Bacterial toxin vaccines. 细菌毒素疫苗。

Advances in biotechnological processes Pub Date : 1990-01-01

J L McDonel

引用次数: 0

Surface chemistry and classification of vaccine adjuvants and vehicles. 疫苗佐剂和载体的表面化学和分类。

Advances in biotechnological processes Pub Date : 1990-01-01

L F Woodard

引用次数: 0

Serum albumin beads possessing slow-release properties for vaccines. 具有疫苗缓释特性的血清白蛋白珠。

Advances in biotechnological processes Pub Date : 1990-01-01

J F Newman

引用次数: 0

Production and control of Neisseria meningitidis vaccines. 脑膜炎奈瑟菌疫苗的生产和控制。

Advances in biotechnological processes Pub Date : 1990-01-01

C E Frasch

引用次数: 0

Production of viral vaccines in stirred bioreactors. 搅拌生物反应器中病毒疫苗的生产。

Advances in biotechnological processes Pub Date : 1990-01-01

J Shevitz, T L LaPorte, T E Stinnett

引用次数: 0

Vaccines against viruses associated with diseases in human central nervous system. 预防与人类中枢神经系统疾病有关的病毒的疫苗。

Advances in biotechnological processes Pub Date : 1990-01-01

S Lustig, E Israeli, Y Akov, D Ben-Nathan

引用次数: 0

Rabies vaccines from Pasteur's time up to experimental subunit vaccines today. 狂犬病疫苗从巴斯德时代一直到今天的实验性亚单位疫苗。

Advances in biotechnological processes Pub Date : 1990-01-01

P Perrin, M Lafon, P Sureau

引用次数: 0

Baculovirus expression vector system for production of viral vaccines. 用于生产病毒疫苗的杆状病毒表达载体系统。

Advances in biotechnological processes Pub Date : 1990-01-01

J M Vlak, R J Keus

引用次数: 0

Pertussis vaccines: present status. 百日咳疫苗:现状。

Advances in biotechnological processes Pub Date : 1990-01-01

M Christodoulides

{"title":"Pertussis vaccines: present status.","authors":"M Christodoulides","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The eradication of pertussis as a worldwide disease is unforeseeable for the present and immediate future. Mortality and morbidity from clinical pertussis are still commonly reported, especially in underdeveloped countries where mass immunization programs are virtually nonexistent. To achieve control of the disease, a high level of immunization coverage is necessary, and pertussis WCPV still remains one of the most effective bacterial vaccines. But, primarily because of its reactogenicity for infants, much effort has been directed toward the characterization of bacterial components important in pathogenesis and for the development of acellular vaccines. Progress in the last decade has resulted in the production and use of such vaccines for routine vaccination, and their use in Japan, as well as the recent clinical trials in Sweden and several phase I/II studies in other countries, has shown that these preparations are safer than conventional WCPV, and equally effective, in preventing disease. The development of future acellular pertussis vaccines by gene manipulation may finally inspire public confidence for vaccine prophylaxis, eventually leading to eradication of the disease. However, the production and use of such sophisticated vaccines is dependent on many factors, and consequently conventional WCPV may still be used in many countries for several years to come.</p>","PeriodicalId":77482,"journal":{"name":"Advances in biotechnological processes","volume":"13 ","pages":"169-99"},"PeriodicalIF":0.0,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13338961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0